<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="publisher-id">JMIR</journal-id><journal-title-group><journal-title>Journal of Medical Internet Research</journal-title></journal-title-group><issn pub-type="ppub">1439-4456</issn><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications Inc.</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24028826</article-id><article-id pub-id-type="pmc">3785973</article-id><article-id pub-id-type="publisher-id">v15i9e188</article-id><article-id pub-id-type="doi">10.2196/jmir.2640</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Long-Term Outcomes of Internet-Based Self-Management Support in Adults With Asthma: Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Eysenbach</surname><given-names>Gunther</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Fonseca</surname><given-names>João A</given-names></name></contrib><contrib contrib-type="reviewer"><name><surname>Ryan</surname><given-names>Dermot</given-names></name></contrib></contrib-group><contrib-group><contrib id="contrib1" contrib-type="author"><name><surname>van Gaalen</surname><given-names>Johanna L</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="contrib2" contrib-type="author"><name><surname>Beerthuizen</surname><given-names>Thijs</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="contrib3" contrib-type="author"><name><surname>van der Meer</surname><given-names>Victor</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="contrib4" contrib-type="author"><name><surname>van Reisen</surname><given-names>Patricia</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="contrib5" contrib-type="author"><name><surname>Redelijkheid</surname><given-names>Geertje W</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="contrib6" contrib-type="author"><name><surname>Snoeck-Stroband</surname><given-names>Jiska B</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="contrib7" contrib-type="author" corresp="yes"><name><surname>Sont</surname><given-names>Jacob K</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><address><institution>Leiden University Medical Center</institution><institution>Department of Medical Decision Making</institution><addr-line>Albinusdreef 2, J-10-86</addr-line><addr-line>Leiden, 2333 ZA</addr-line><country>Netherlands</country><phone>31 715264578</phone><fax>31 715266838</fax><email>j.k.sont@lumc.nl</email></address></contrib><contrib id="contrib8" contrib-type="author" equal-contrib="yes"><collab>SMASHING Study Group</collab><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1" rid="aff1"><sup>1</sup><institution>Leiden University Medical Center</institution><institution>Department of Medical Decision Making</institution><addr-line>Leiden</addr-line><country>Netherlands</country></aff><author-notes><corresp>Corresponding Author: Jacob K Sont <email>j.k.sont@lumc.nl</email></corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>12</day><month>9</month><year>2013</year></pub-date><volume>15</volume><issue>9</issue><elocation-id>e188</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2013</year></date><date date-type="rev-request"><day>21</day><month>4</month><year>2013</year></date><date date-type="rev-recd"><day>21</day><month>5</month><year>2013</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2013</year></date></history><permissions><copyright-statement>©Johanna L van Gaalen, Thijs Beerthuizen, Victor van der Meer, Patricia van Reisen, Geertje W Redelijkheid, Jiska B Snoeck-Stroband, Jacob K Sont, SMASHING Study Group. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 12.09.2013. </copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0/">http://creativecommons.org/licenses/by/2.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://www.jmir.org/,">http://www.jmir.org/,</ext-link> as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="http://www.jmir.org/2013/9/e188/"></self-uri><abstract><sec sec-type="background"><title><offsets xml_i="5551" xml_f="5561" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="5572" xml_f="6473" txt_i="22" txt_f="923">Long-term asthma management falls short of the goals set by international guidelines. The Internet is proposed as an attractive medium to support guided self-management in asthma. Recently, in a multicenter, pragmatic randomized controlled parallel trial with a follow-up period of 1 year, patients were allocated Internet-based self-management (IBSM) support (Internet group [IG]) or usual care (UC) alone. IBSM support was automatically terminated after 12 months of follow-up. In this study, IBSM support has been demonstrated to improve asthma-related quality of life, asthma control, lung function, and the number of symptom-free days as compared to UC. IBSM support was based on known key components for effective self-management and included weekly asthma control monitoring and treatment advice, online and group education, and communication (both online and offline) with a respiratory nurse.</offsets></p></sec><sec sec-type="objective"><title><offsets xml_i="6516" xml_f="6525" txt_i="925" txt_f="934">Objective</offsets></title><p><offsets xml_i="6536" xml_f="6668" txt_i="935" txt_f="1067">The objective of the study was to assess the long-term effects of providing patients 1 year of IBSM support as compared to UC alone.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="6709" xml_f="6716" txt_i="1069" txt_f="1076">Methods</offsets></title><p><offsets xml_i="6727" xml_f="7291" txt_i="1077" txt_f="1641">Two hundred adults with physician-diagnosed asthma (3 or more months of inhaled corticosteroids prescribed in the past year) from 37 general practices and 1 academic outpatient department who previously participated were invited by letter for additional follow-up at 1.5 years after finishing the study. The Asthma Control Questionnaire (ACQ) and the Asthma Quality of Life Questionnaire (AQLQ) were completed by 107 participants (60 UC participants and 47 IG participants). A minimal clinical important difference in both questionnaires is 0.5 on a 7-point scale.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="7332" xml_f="7339" txt_i="1643" txt_f="1650">Results</offsets></title><p><offsets xml_i="7350" xml_f="7714" txt_i="1651" txt_f="2015">At 30 months after baseline, a sustained and significant difference in terms of asthma-related quality of life of 0.29 (95% CI 0.01-0.57) and asthma control of -0.33 (95% CI -0.61 to -0.05) was found in favor of the IBSM group. No such differences were found for inhaled corticosteroid dosage or for lung function, measured as forced expiratory volume in 1 second.</offsets></p></sec><sec sec-type="conclusions"><title><offsets xml_i="7759" xml_f="7770" txt_i="2017" txt_f="2028">Conclusions</offsets></title><p><offsets xml_i="7781" xml_f="8064" txt_i="2029" txt_f="2312">Improvements in asthma-related quality of life and asthma control were sustained in patients who received IBSM support for 1 year, even up to 1.5 years after terminating support. Future research should be focused on implementation of IBSM on a wider scale within routine asthma care.</offsets></p></sec><sec><title><offsets xml_i="8086" xml_f="8104" txt_i="2314" txt_f="2332">Trial Registration</offsets></title><p><offsets xml_i="8115" xml_f="8303" txt_i="2333" txt_f="2521">International Standard Randomized Controlled Trial Number (ISRCTN): 79864465; http://www.controlled-trials.com/ISRCTN79864465 (Archived by WebCite at http://www.webcitation.org/6J4VHhPk4).</offsets></p></sec></abstract><kwd-group><kwd>asthma</kwd><kwd>quality of life</kwd><kwd>self-management</kwd><kwd>long-term</kwd><kwd>eHealth</kwd><kwd>Internet</kwd><kwd>telemedicine</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="8537" xml_f="8549" txt_i="2530" txt_f="2542">Introduction</offsets></title><p><offsets xml_i="8560" xml_f="8647" txt_i="2543" txt_f="2630">Asthma is a common chronic disease with a prevalence of approximately 6% among adults [</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="8680" xml_f="8681" txt_i="2630" txt_f="2631">1</offsets></xref><offsets xml_i="8688" xml_f="8880" txt_i="2631" txt_f="2823">]. It is characterized by chronic inflammation and/or structural changes of the airways, which leads to recurrent episodes of wheezing, coughing, difficulty breathing, and/or chest tightness [</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="8913" xml_f="8914" txt_i="2823" txt_f="2824">2</offsets></xref><offsets xml_i="8921" xml_f="8922" txt_i="2824" txt_f="2825">,</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="8955" xml_f="8956" txt_i="2825" txt_f="2826">3</offsets></xref><offsets xml_i="8963" xml_f="9000" txt_i="2826" txt_f="2863">]. According to clinical guidelines [</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="9033" xml_f="9034" txt_i="2863" txt_f="2864">2</offsets></xref><offsets xml_i="9041" xml_f="9042" txt_i="2864" txt_f="2865">,</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="9075" xml_f="9076" txt_i="2865" txt_f="2866">3</offsets></xref><offsets xml_i="9083" xml_f="9372" txt_i="2866" txt_f="3155">], treatment strategies for asthma should be aimed at minimization of symptoms, optimization of lung function, and prevention of symptom aggravation with few medication side effects. Even though effective therapies are widely available, many patients do not achieve these treatment goals [</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="9405" xml_f="9406" txt_i="3155" txt_f="3156">1</offsets></xref><offsets xml_i="9413" xml_f="9414" txt_i="3156" txt_f="3157">,</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="9447" xml_f="9448" txt_i="3157" txt_f="3158">4</offsets></xref><offsets xml_i="9455" xml_f="9792" txt_i="3158" txt_f="3495">]. As a consequence, asthma still imposes a significant burden of disease on the individual patient. A proactive patient-centered approach consisting of education, treatment goals, self-monitoring, and an action plan, accompanied by guidance and regular review by a health care provider, has the potential to improve outcomes in asthma [</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="9825" xml_f="9826" txt_i="3495" txt_f="3496">5</offsets></xref><offsets xml_i="9833" xml_f="10047" txt_i="3496" txt_f="3710">], including improved quality of life and a reduced number of hospitalizations and unscheduled doctor visits. In spite of the prominent role within guidelines, adoption of this “guided self-management” is lacking [</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="10080" xml_f="10081" txt_i="3710" txt_f="3711">6</offsets></xref><offsets xml_i="10088" xml_f="10248" txt_i="3711" txt_f="3871">]. While many practices do offer patients a routine medical review, only a minority of patients are provided with an action plan by their health care provider [</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="10281" xml_f="10282" txt_i="3871" txt_f="3872">7</offsets></xref><offsets xml_i="10289" xml_f="10290" txt_i="3872" txt_f="3873">,</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="10323" xml_f="10324" txt_i="3873" txt_f="3874">8</offsets></xref><offsets xml_i="10331" xml_f="10516" txt_i="3874" txt_f="4059">]. Usage of action plans by patients could be enhanced if action plans are part of a patient-professional partnership and when they are tailored to the needs of the individual patient [</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="10549" xml_f="10550" txt_i="4059" txt_f="4060">9</offsets></xref><offsets xml_i="10557" xml_f="10559" txt_i="4060" txt_f="4062">].</offsets></p><p><offsets xml_i="10566" xml_f="10663" txt_i="4063" txt_f="4160">Provision of Internet technology has been proposed as an appealing medium for asthma management [</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="10697" xml_f="10699" txt_i="4160" txt_f="4162">10</offsets></xref><offsets xml_i="10706" xml_f="10707" txt_i="4162" txt_f="4163">-</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="10741" xml_f="10743" txt_i="4163" txt_f="4165">14</offsets></xref><offsets xml_i="10750" xml_f="10797" txt_i="4165" txt_f="4212">]. Indeed, in the study by Van der Meer et al [</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="10831" xml_f="10833" txt_i="4212" txt_f="4214">15</offsets></xref><offsets xml_i="10840" xml_f="11191" txt_i="4214" txt_f="4565">] in patients with mild to moderate persistent asthma, it was demonstrated that provision of an Internet-based self-management (IBSM) support program for 1 year leads to improved asthma-related quality of life, asthma control, lung function, and the number of symptom-free days as compared to usual care (UC) alone. A post hoc analysis of this study [</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="11225" xml_f="11227" txt_i="4565" txt_f="4567">16</offsets></xref><offsets xml_i="11234" xml_f="11676" txt_i="4567" txt_f="5009">] demonstrated that patients with asthma that was not well controlled benefited the most from IBSM support. In addition, this study showed that at 12 months of follow-up, about 60% of the patients were still using the program of their own initiative. However, it is unknown whether the benefits are sustained over a long-term period. We hypothesized that the benefits of providing 1 year of IBSM support are sustained over a long-term period.</offsets></p><p><offsets xml_i="11683" xml_f="11806" txt_i="5010" txt_f="5133">In this paper, we aim to assess the long-term effects of providing patients 1 year of IBSM support as compared to UC alone.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="11847" xml_f="11854" txt_i="5135" txt_f="5142">Methods</offsets></title><sec><title><offsets xml_i="11874" xml_f="11886" txt_i="5143" txt_f="5155">Participants</offsets></title><p><offsets xml_i="11897" xml_f="12302" txt_i="5156" txt_f="5561">Two hundred patients who previously participated in a 12-month multicenter, nonblinded, pragmatic randomized controlled parallel trial were invited for additional follow-up 1.5 years after finishing the study. Full details of the study methodology and subjects for the Self-Management of Asthma Supported by Hospitals, ICT, Nurses and General practitioners (SMASHING) study have been published elsewhere [</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="12336" xml_f="12338" txt_i="5561" txt_f="5563">15</offsets></xref><offsets xml_i="12345" xml_f="12903" txt_i="5563" txt_f="6121">]. Briefly, patients were recruited from 37 general practices in the Leiden and The Hague area and from the outpatient clinic of the department of Respiratory Medicine of the Leiden University Medical Center (LUMC), the Netherlands. Eligibility criteria were adult age (18-50 years), physician-diagnosed asthma, prescription of inhaled corticosteroids ≥3 months in the previous year, access to Internet at home, and the ability to understand written and oral Dutch instructions. Patients who received a maintenance dose of oral corticosteroids were excluded.</offsets></p><p><offsets xml_i="12910" xml_f="13040" txt_i="6122" txt_f="6252">All participants were trained in a group educational session to measure lung function as forced expiratory volume in 1 second (FEV</offsets><sub><offsets xml_i="13045" xml_f="13046" txt_i="6252" txt_f="6253">1</offsets></sub><offsets xml_i="13052" xml_f="13204" txt_i="6253" txt_f="6405">) by using a handheld electronic spirometer (PiKo-1, Ferraris Respiratory). After this session, patients were asked to report during a 2-week period FEV</offsets><sub><offsets xml_i="13209" xml_f="13210" txt_i="6405" txt_f="6406">1</offsets></sub><offsets xml_i="13216" xml_f="13338" txt_i="6406" txt_f="6528"> (daily), day and night symptom score (daily), and to fill in at least once weekly an Asthma Control Questionnaire (ACQ) [</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="13372" xml_f="13374" txt_i="6528" txt_f="6530">17</offsets></xref><offsets xml_i="13381" xml_f="13631" txt_i="6530" txt_f="6780">] on a specifically designed website or by mobile phone text messaging (SMS). The ACQ is a validated 7-item questionnaire for assessment of actual level of asthma control, consisting of 6 questions on asthma symptoms in the previous 7 days and an FEV</offsets><sub><offsets xml_i="13636" xml_f="13637" txt_i="6780" txt_f="6781">1</offsets></sub><offsets xml_i="13643" xml_f="13759" txt_i="6781" txt_f="6897"> measurement. Optimal cut-point for “well-controlled” is ≤0.75 and a value of ≥1.50 confirms “uncontrolled” asthma [</offsets><xref ref-type="bibr" rid="ref18"><offsets xml_i="13793" xml_f="13795" txt_i="6897" txt_f="6899">18</offsets></xref><offsets xml_i="13802" xml_f="13901" txt_i="6899" txt_f="6998">]. During these 2 weeks, patients did not receive feedback on their actual level of asthma control.</offsets></p><p><offsets xml_i="13908" xml_f="14458" txt_i="6999" txt_f="7549">After the 2-week period, all patients were randomized to either IBSM support adjacent to UC, that is, Internet group (IG), or to UC alone. Strategy allocation of patients on a 1:1 ratio was conducted by JKS using a computer-generated permuted block scheme. Patients were stratified on care provider (general practice vs outpatient clinic) and asthma control at baseline. The SMASHING study was powered to detect a difference in the primary outcome asthma-related quality of life, as measured by the Asthma Quality of Life Questionnaire (AQLQ) score [</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="14492" xml_f="14494" txt_i="7549" txt_f="7551">19</offsets></xref><offsets xml_i="14501" xml_f="14809" txt_i="7551" txt_f="7859">] between the two groups. Due to the nature of the intervention and its pragmatic character, researchers were not blinded for group allocation. This study was approved by the ethical committee of the LUMC, the Netherlands, and was conducted in concordance with the principles of the Declaration of Helsinki [</offsets><xref ref-type="bibr" rid="ref20"><offsets xml_i="14843" xml_f="14845" txt_i="7859" txt_f="7861">20</offsets></xref><offsets xml_i="14852" xml_f="14980" txt_i="7861" txt_f="7989">], as amended in Seoul 2008. The trial conformed to the Consolidated Standards of Reporting Trials (CONSORT)-eHealth Checklist (</offsets><xref ref-type="app" rid="app1"><offsets xml_i="15012" xml_f="15033" txt_i="7989" txt_f="8010">Multimedia Appendix 1</offsets></xref><offsets xml_i="15040" xml_f="15043" txt_i="8010" txt_f="8013">) [</offsets><xref ref-type="bibr" rid="ref21"><offsets xml_i="15077" xml_f="15079" txt_i="8013" txt_f="8015">21</offsets></xref><offsets xml_i="15086" xml_f="15088" txt_i="8015" txt_f="8017">].</offsets></p></sec><sec><title><offsets xml_i="15110" xml_f="15156" txt_i="8019" txt_f="8065">Internet-Based Self-Management Support Program</offsets></title><p><offsets xml_i="15167" xml_f="15218" txt_i="8066" txt_f="8117">The IBSM support program is based on focus groups [</offsets><xref ref-type="bibr" rid="ref22"><offsets xml_i="15252" xml_f="15254" txt_i="8117" txt_f="8119">22</offsets></xref><offsets xml_i="15261" xml_f="15288" txt_i="8119" txt_f="8146">], the Chronic Care model [</offsets><xref ref-type="bibr" rid="ref23"><offsets xml_i="15322" xml_f="15324" txt_i="8146" txt_f="8148">23</offsets></xref><offsets xml_i="15331" xml_f="15390" txt_i="8148" txt_f="8207">], and known key components for effective self-management [</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="15423" xml_f="15424" txt_i="8207" txt_f="8208">5</offsets></xref><offsets xml_i="15431" xml_f="15582" txt_i="8208" txt_f="8359">]. The program was aimed at supporting patients in conducting self-management activities and developing a patient-provider partnership in asthma care [</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="15615" xml_f="15616" txt_i="8359" txt_f="8360">3</offsets></xref><offsets xml_i="15623" xml_f="16338" txt_i="8360" txt_f="9072">]. Focus groups were conducted to explore barriers for conducting self-management skills and to identify the potential role of an IBSM support tool. In particular, patients with asthma that was not well controlled (ACQ&gt;0.75) were motivated to use novel information and communication technologies for management of their disease. The Chronic Care model is aimed at improving health care outcomes for patients with a chronic disease by means of a proactive patient-professional partnership that addresses both organizational factors (eg, decision support systems) and resources (eg, self-management support). We incorporated modules for electronic monitoring of asthma control and lung function (weekly ACQ and FEV</offsets><sub><offsets xml_i="16343" xml_f="16344" txt_i="9072" txt_f="9073">1</offsets></sub><offsets xml_i="16350" xml_f="16436" txt_i="9073" txt_f="9159">), a personal action plan, communication with a respiratory nurse (RN), and education.</offsets></p><p><offsets xml_i="16443" xml_f="16514" txt_i="9160" txt_f="9231">During 12 months of follow-up, IG patients had access to IBSM support (</offsets><xref ref-type="app" rid="app2"><offsets xml_i="16546" xml_f="16567" txt_i="9231" txt_f="9252">Multimedia Appendix 2</offsets></xref><offsets xml_i="16574" xml_f="17319" txt_i="9252" txt_f="9997">); after this period, IBSM support (including access to the website) was automatically terminated. Patients were instructed on how they could log in by using a personal username and password and how to use their personal action plan. The program included reminder options for monitoring activities (ie, ACQ, day and night symptom score, lung function), which were initially sent once weekly by either email or mobile phone SMS text messaging, but during follow-up frequency could be adjusted according to the preferences of the individual patient. Patients received immediate feedback (to maintain, step up or step down in medication, and/or to contact a health care professional) on self-monitoring outcomes according to a treatment algorithm (</offsets><xref ref-type="fig" rid="figure1"><offsets xml_i="17354" xml_f="17362" txt_i="9997" txt_f="10005">Figure 1</offsets></xref><offsets xml_i="17369" xml_f="17429" txt_i="10005" txt_f="10065">) and a predefined action plan based on 6 medication steps (</offsets><xref ref-type="table" rid="table1"><offsets xml_i="17465" xml_f="17472" txt_i="10065" txt_f="10072">Table 1</offsets></xref><offsets xml_i="17479" xml_f="17481" txt_i="10072" txt_f="10074">).</offsets></p><p><offsets xml_i="17488" xml_f="17838" txt_i="10075" txt_f="10425">Five respiratory physicians, two general practitioners with a particular focus on respiratory diseases, and two respiratory epidemiologists participated in the development of this algorithm. Action plans of patients were based on their actual medication at the time of study enrollment. Treatment steps corresponded with (inter) national guidelines [</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="17871" xml_f="17872" txt_i="10425" txt_f="10426">3</offsets></xref><offsets xml_i="17879" xml_f="17880" txt_i="10426" txt_f="10427">,</offsets><xref ref-type="bibr" rid="ref24"><offsets xml_i="17914" xml_f="17916" txt_i="10427" txt_f="10429">24</offsets></xref><offsets xml_i="17923" xml_f="18165" txt_i="10429" txt_f="10671">] on asthma management. Briefly, asthma medication can be aimed at (1) decreasing of airway narrowing (ie, beta2-agonists), and/or (2) decreasing airway inflammation (ie, glucocorticosteroids, leukotriene modifiers). A traffic light display (</offsets><xref ref-type="fig" rid="figure2"><offsets xml_i="18200" xml_f="18208" txt_i="10671" txt_f="10679">Figure 2</offsets></xref><offsets xml_i="18215" xml_f="18396" txt_i="10679" txt_f="10848">) was used to indicate the level of asthma control: green (well-controlled, ACQ≤0.5), yellow (0.5&lt;ACQ&lt;1.0), orange (1.0&lt;ACQ&lt;1.5), and red (uncontrolled, ACQ score≥1.50).</offsets></p><p><offsets xml_i="18403" xml_f="19126" txt_i="10849" txt_f="11572">After each medication change, a 4-week evaluation period commenced during which no advice to change treatment was given, except in the case of symptom deterioration. E-messaging, telephone, or Web-based communication allowed patients to interact with the RN. Additionally, the RN supported patients by nurse-initiated communication characterized by a supportive style to give positive feedback on achieved successes (eg, step-down in medication) or to inquire for reasons on not following treatment advice (eg, side effects). The RN reminded patients to fill in research questionnaires at 12 months of follow-up. On average, the RN spent 1-2 hours per week on patient- and nurse-initiated communication for all IG patients.</offsets></p><p><offsets xml_i="19133" xml_f="19754" txt_i="11573" txt_f="12194">Education components of IBSM support were provided both online (eg, educational pages, newsfeed) and offline. Offline education consisted of a group education session that dealt with topics related to asthma self-management, usage of the IBSM tool, and designing an action plan based on current medication. Online information was based on information provided by the Lung Foundation Netherlands. Newsfeed content was kept up to date and contained items related to asthma and management of chronic diseases (eg, healthy lifestyle). During the study, neither major content/functionality changes nor bug fixes were required.</offsets></p><p><offsets xml_i="19761" xml_f="20025" txt_i="12195" txt_f="12459">Program content was developed by JKS in close collaboration with the departments of Public Health and Primary Care (LUMC), Respiratory Medicine (LUMC, Amsterdam Medical Center), and Haga Teaching Hospital, The Hague. Software was developed by Furore BV, Amsterdam.</offsets></p><table-wrap id="table1" position="float"><label><offsets xml_i="20077" xml_f="20084" txt_i="12460" txt_f="12467">Table 1</offsets></label><caption><p><offsets xml_i="20104" xml_f="20131" txt_i="12467" txt_f="12494">Medication treatment steps.</offsets></p></caption><table frame="hsides" rules="groups" width="616" border="0" cellpadding="7" cellspacing="0"><col width="69" span="1"></col><col width="519" span="1"></col><thead><tr valign="bottom"><td rowspan="1" colspan="1"><offsets xml_i="20355" xml_f="20359" txt_i="12495" txt_f="12499">Step</offsets><sup><offsets xml_i="20364" xml_f="20365" txt_i="12499" txt_f="12500">a</offsets></sup><offsets xml_i="20371" xml_f="20372" txt_i="12500" txt_f="12501">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20405" xml_f="20415" txt_i="12502" txt_f="12512">Medication</offsets></td></tr></thead><tbody><tr valign="bottom"><td rowspan="1" colspan="1"><offsets xml_i="20488" xml_f="20489" txt_i="12513" txt_f="12514">1</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20522" xml_f="20558" txt_i="12515" txt_f="12551">As needed rapid-acting beta2-agonist</offsets><sup><offsets xml_i="20563" xml_f="20564" txt_i="12551" txt_f="12552">b</offsets></sup><offsets xml_i="20570" xml_f="20571" txt_i="12552" txt_f="12553">
</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="20626" xml_f="20627" txt_i="12554" txt_f="12555">2</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20660" xml_f="20697" txt_i="12556" txt_f="12593">Low-dose inhaled glucocorticosteroids</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="20752" xml_f="20754" txt_i="12594" txt_f="12596">3a</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20787" xml_f="20852" txt_i="12597" txt_f="12662">Low-dose inhaled glucocorticosteroids + long-acting beta2-agonist</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="20907" xml_f="20909" txt_i="12663" txt_f="12665">3b</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20942" xml_f="20982" txt_i="12666" txt_f="12706">Medium-dose inhaled glucocorticosteroids</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="21037" xml_f="21039" txt_i="12707" txt_f="12709">3c</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21072" xml_f="21110" txt_i="12710" txt_f="12748">High-dose inhaled glucocorticosteroids</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="21165" xml_f="21167" txt_i="12749" txt_f="12751">4a</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21200" xml_f="21268" txt_i="12752" txt_f="12820">Medium-dose inhaled glucocorticosteroids + long-acting beta2-agonist</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="21323" xml_f="21325" txt_i="12821" txt_f="12823">4b</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21358" xml_f="21424" txt_i="12824" txt_f="12890">High-dose inhaled glucocorticosteroids + long-acting beta2-agonist</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="21479" xml_f="21481" txt_i="12891" txt_f="12893">4c</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21514" xml_f="21597" txt_i="12894" txt_f="12977">Contact RN or other health care provider: consider addition of leukotriene modifier</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="21652" xml_f="21653" txt_i="12978" txt_f="12979">5</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21686" xml_f="21774" txt_i="12980" txt_f="13068">Contact RN or other health care provider: consider addition of oral glucocorticosteroids</offsets></td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><offsets xml_i="21839" xml_f="21840" txt_i="13069" txt_f="13070">
</offsets><sup><offsets xml_i="21845" xml_f="21846" txt_i="13070" txt_f="13071">a</offsets></sup><offsets xml_i="21852" xml_f="21913" txt_i="13071" txt_f="13132">Step numbers correspond with GINA guideline treatment steps [</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="21946" xml_f="21947" txt_i="13132" txt_f="13133">3</offsets></xref><offsets xml_i="21954" xml_f="21956" txt_i="13133" txt_f="13135">].</offsets></p></fn><fn id="table1fn2"><p><offsets xml_i="21987" xml_f="21988" txt_i="13136" txt_f="13137">
</offsets><sup><offsets xml_i="21993" xml_f="21994" txt_i="13137" txt_f="13138">b</offsets></sup><offsets xml_i="22000" xml_f="22062" txt_i="13138" txt_f="13200">Applies to all treatment steps as this is reliever medication.</offsets></p></fn></table-wrap-foot></table-wrap><fig id="figure1" position="float"><label><offsets xml_i="22144" xml_f="22152" txt_i="13201" txt_f="13209">Figure 1</offsets></label><caption><p><offsets xml_i="22172" xml_f="22192" txt_i="13209" txt_f="13229">Treatment algorithm.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig1"></graphic></fig><fig id="figure2" position="float"><label><offsets xml_i="22306" xml_f="22314" txt_i="13230" txt_f="13238">Figure 2</offsets></label><caption><p><offsets xml_i="22334" xml_f="22356" txt_i="13238" txt_f="13260">Traffic light display.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig2"></graphic></fig></sec><sec><title><offsets xml_i="22446" xml_f="22456" txt_i="13262" txt_f="13272">Usual Care</offsets></title><p><offsets xml_i="22467" xml_f="22603" txt_i="13273" txt_f="13409">Patients allocated to UC received care as usual by their health care provider. According to the Dutch College of General Practitioners [</offsets><xref ref-type="bibr" rid="ref24"><offsets xml_i="22637" xml_f="22639" txt_i="13409" txt_f="13411">24</offsets></xref><offsets xml_i="22646" xml_f="22771" txt_i="13411" txt_f="13536">], each patient should be provided with a (paper-based) action plan and be invited for a medical review at least once a year.</offsets></p></sec><sec><title><offsets xml_i="22793" xml_f="22838" txt_i="13538" txt_f="13583">Additional Follow-Up 30 Months After Baseline</offsets></title><p><offsets xml_i="22849" xml_f="23041" txt_i="13584" txt_f="13776">Patients who previously participated were invited, by a letter containing information on the follow-up measurements, to attend the LUMC for follow-up measurements at 30 months after baseline (</offsets><xref ref-type="table" rid="table2"><offsets xml_i="23077" xml_f="23084" txt_i="13776" txt_f="13783">Table 2</offsets></xref><offsets xml_i="23091" xml_f="23451" txt_i="13783" txt_f="14143">). Nonresponding patients received a reminder letter within 2-4 weeks and an additional telephone call. All participants gave written informed consent during this visit, prior to obtaining measurements. Patients were asked to report on their daily dose of inhaled corticosteroids (ICS) and to complete 2 paper-based questionnaires, namely an ACQ (including FEV</offsets><sub><offsets xml_i="23456" xml_f="23457" txt_i="14143" txt_f="14144">1</offsets></sub><offsets xml_i="23463" xml_f="23478" txt_i="14144" txt_f="14159">) and an AQLQ [</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="23512" xml_f="23514" txt_i="14159" txt_f="14161">19</offsets></xref><offsets xml_i="23521" xml_f="23695" txt_i="14161" txt_f="14335">], a validated 21-item questionnaire for assessment of asthma-related quality of life. The minimal clinical important difference for the ACQ is -0.5 and for the AQLQ is 0.5 [</offsets><xref ref-type="bibr" rid="ref25"><offsets xml_i="23729" xml_f="23731" txt_i="14335" txt_f="14337">25</offsets></xref><offsets xml_i="23738" xml_f="23739" txt_i="14337" txt_f="14338">,</offsets><xref ref-type="bibr" rid="ref26"><offsets xml_i="23773" xml_f="23775" txt_i="14338" txt_f="14340">26</offsets></xref><offsets xml_i="23782" xml_f="23913" txt_i="14340" txt_f="14471">]. Both questionnaires have a 7-point scale. Patients were asked to withhold short-acting beta2-agonists for 6-8 hours prior to FEV</offsets><sub><offsets xml_i="23918" xml_f="23919" txt_i="14471" txt_f="14472">1</offsets></sub><offsets xml_i="23925" xml_f="24195" txt_i="14472" txt_f="14742"> measurement. Questionnaires were sent in the mail to patients who were unable or unwilling to attend the LUMC, and an additional home visit was scheduled in case of unavailability of a Piko-1 meter. Inhaled corticosteroid doses were reported as fluticasone equivalents.</offsets></p></sec><sec><title><offsets xml_i="24217" xml_f="24237" txt_i="14744" txt_f="14764">Statistical Analysis</offsets></title><p><offsets xml_i="24248" xml_f="24401" txt_i="14765" txt_f="14918">Differences in characteristics at baseline (null months) were analyzed between participants and nonparticipants of both groups (UC and IG) with unpaired </offsets><italic><offsets xml_i="24409" xml_f="24410" txt_i="14918" txt_f="14919">t</offsets></italic><offsets xml_i="24419" xml_f="24451" txt_i="14919" txt_f="14951"> tests. ACQ and AQLQ scores, FEV</offsets><sub><offsets xml_i="24456" xml_f="24457" txt_i="14951" txt_f="14952">1</offsets></sub><offsets xml_i="24463" xml_f="24705" txt_i="14952" txt_f="15194">, and daily ICS dose were compared between participants from both groups by applying linear mixed-effect models. ICS doses were reported as fluticasone equivalents. Within- and between-group differences were analyzed with paired and unpaired </offsets><italic><offsets xml_i="24713" xml_f="24714" txt_i="15194" txt_f="15195">t</offsets></italic><offsets xml_i="24723" xml_f="24957" txt_i="15195" txt_f="15426"> tests, respectively. Statistical analyses were carried out by intention to treat. For analysis, Stata 9.2 was used. Subgroup analyses were conducted for patients with well-controlled (ACQ≤0.75) and uncontrolled asthma (ACQ&gt;0.75) [</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="24991" xml_f="24993" txt_i="15426" txt_f="15428">17</offsets></xref><offsets xml_i="25000" xml_f="25014" txt_i="15428" txt_f="15442">] at baseline.</offsets></p><table-wrap id="table2" position="float"><label><offsets xml_i="25066" xml_f="25073" txt_i="15443" txt_f="15450">Table 2</offsets></label><caption><p><offsets xml_i="25093" xml_f="25110" txt_i="15450" txt_f="15467">Outcome measures.</offsets></p></caption><table frame="hsides" rules="groups" width="616" border="0" cellpadding="7" cellspacing="0"><col width="15" span="1"></col><col width="218" span="1"></col><col width="50" span="1"></col><col width="63" span="1"></col><col width="70" span="1"></col><col width="129" span="1"></col><thead><tr valign="top"><td rowspan="2" colspan="2"><offsets xml_i="25456" xml_f="25471" txt_i="15468" txt_f="15483">Characteristics</offsets></td><td colspan="3" rowspan="1"><offsets xml_i="25504" xml_f="25526" txt_i="15484" txt_f="15506">IBSM support (IG only)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25559" xml_f="25560" txt_i="15507" txt_f="15508">
</offsets><break></break><offsets xml_i="25575" xml_f="25576" txt_i="15508" txt_f="15509">
</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="25631" xml_f="25639" txt_i="15510" txt_f="15518">Baseline</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25672" xml_f="25680" txt_i="15519" txt_f="15527">3 months</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25713" xml_f="25722" txt_i="15528" txt_f="15537">12 months</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25755" xml_f="25785" txt_i="15538" txt_f="15568">30 months/additional follow-up</offsets></td></tr></thead><tbody><tr valign="top"><td colspan="6" rowspan="1"><offsets xml_i="25855" xml_f="25856" txt_i="15569" txt_f="15570">
</offsets><bold><offsets xml_i="25862" xml_f="25870" txt_i="15570" txt_f="15578">Clinical</offsets></bold><offsets xml_i="25877" xml_f="25878" txt_i="15578" txt_f="15579">
</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="25933" xml_f="25934" txt_i="15580" txt_f="15581">
</offsets><break></break><offsets xml_i="25949" xml_f="25950" txt_i="15581" txt_f="15582">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25983" xml_f="26003" txt_i="15583" txt_f="15603">Asthma control (ACQ)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26036" xml_f="26037" txt_i="15604" txt_f="15605">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26070" xml_f="26071" txt_i="15606" txt_f="15607">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26104" xml_f="26105" txt_i="15608" txt_f="15609">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26138" xml_f="26139" txt_i="15610" txt_f="15611">X</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="26194" xml_f="26195" txt_i="15612" txt_f="15613">
</offsets><break></break><offsets xml_i="26210" xml_f="26211" txt_i="15613" txt_f="15614">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26244" xml_f="26262" txt_i="15615" txt_f="15633">Lung function (FEV</offsets><sub><offsets xml_i="26267" xml_f="26268" txt_i="15633" txt_f="15634">1</offsets></sub><offsets xml_i="26274" xml_f="26275" txt_i="15634" txt_f="15635">)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26308" xml_f="26309" txt_i="15636" txt_f="15637">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26342" xml_f="26343" txt_i="15638" txt_f="15639">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26376" xml_f="26377" txt_i="15640" txt_f="15641">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26410" xml_f="26411" txt_i="15642" txt_f="15643">X</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="26466" xml_f="26467" txt_i="15644" txt_f="15645">
</offsets><break></break><offsets xml_i="26482" xml_f="26483" txt_i="15645" txt_f="15646">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26516" xml_f="26544" txt_i="15647" txt_f="15675">Daily inhaled corticosteroid</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26577" xml_f="26578" txt_i="15676" txt_f="15677">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26611" xml_f="26612" txt_i="15678" txt_f="15679">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26645" xml_f="26646" txt_i="15680" txt_f="15681">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26679" xml_f="26680" txt_i="15682" txt_f="15683">X</offsets></td></tr><tr valign="top"><td colspan="6" rowspan="1"><offsets xml_i="26735" xml_f="26736" txt_i="15684" txt_f="15685">
</offsets><bold><offsets xml_i="26742" xml_f="26757" txt_i="15685" txt_f="15700">Quality of life</offsets></bold><offsets xml_i="26764" xml_f="26765" txt_i="15700" txt_f="15701">
</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="26820" xml_f="26821" txt_i="15702" txt_f="15703">
</offsets><break></break><offsets xml_i="26836" xml_f="26837" txt_i="15703" txt_f="15704">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26870" xml_f="26907" txt_i="15705" txt_f="15742">Asthma-related quality of life (AQLQ)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26940" xml_f="26941" txt_i="15743" txt_f="15744">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26974" xml_f="26975" txt_i="15745" txt_f="15746">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="27008" xml_f="27009" txt_i="15747" txt_f="15748">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="27042" xml_f="27043" txt_i="15749" txt_f="15750">X</offsets></td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="results"><title><offsets xml_i="27125" xml_f="27132" txt_i="15753" txt_f="15760">Results</offsets></title><sec><title><offsets xml_i="27152" xml_f="27167" txt_i="15761" txt_f="15776">Characteristics</offsets></title><p><offsets xml_i="27178" xml_f="27325" txt_i="15777" txt_f="15924">In total, 107 out of 200 (54%) invited patients consented to participate for additional follow-up at 1.5 years after finishing the SMASHING study (</offsets><xref ref-type="fig" rid="figure3"><offsets xml_i="27360" xml_f="27368" txt_i="15924" txt_f="15932">Figure 3</offsets></xref><offsets xml_i="27375" xml_f="27456" txt_i="15932" txt_f="16013">), of whom 60 patients were previously allocated to UC and 47 patients to the IG.</offsets></p><p><offsets xml_i="27463" xml_f="27554" txt_i="16014" txt_f="16105">Participants in the IG differed in baseline ACQ scores from nonparticipants (0.93 vs 1.29; </offsets><italic><offsets xml_i="27562" xml_f="27563" txt_i="16105" txt_f="16106">P</offsets></italic><offsets xml_i="27572" xml_f="27743" txt_i="16106" txt_f="16277">=.009). Apart from these differences, no other differences in clinical characteristics at baseline between participants and nonparticipants in each group were identified. </offsets><xref ref-type="table" rid="table2"><offsets xml_i="27779" xml_f="27786" txt_i="16277" txt_f="16284">Table 2</offsets></xref><offsets xml_i="27793" xml_f="27917" txt_i="16284" txt_f="16408"> gives an overview of baseline characteristics of study participants. Baseline characteristics of both groups were similar (</offsets><xref ref-type="table" rid="table3"><offsets xml_i="27953" xml_f="27960" txt_i="16408" txt_f="16415">Table 3</offsets></xref><offsets xml_i="27967" xml_f="27969" txt_i="16415" txt_f="16417">).</offsets></p></sec><sec><title><offsets xml_i="27991" xml_f="28008" txt_i="16419" txt_f="16436">Clinical Outcomes</offsets></title><p><offsets xml_i="28019" xml_f="28718" txt_i="16437" txt_f="17136">Twelve months after baseline, significant improved outcomes in favor of the IG were demonstrated for asthma-related quality of life (AQLQ) at 0.37 (95% CI 0.14-0.61) and asthma control of -0.57 (95% CI -0.88 to -0.26) as compared with UC. For those who participated at 30 months, a difference in ACQ score between baseline and 12 months was 0.43 (95% CI 0.21-0.66) in favor of the IG. For those who did not participate at 30 months, a difference between baseline and 12 months of 0.34 (95% CI 0.06-0.61) in favor of the IG was detected. However, there was no significant difference in effect (in ACQ score between 0 and 12 months) between participants (0.43) and nonparticipants (0.33) at 30 months.</offsets></p><p><offsets xml_i="28725" xml_f="28978" txt_i="17137" txt_f="17390">At 30 months after baseline, a significant and slightly attenuated improvement was shown for both AQLQ (adjusted between-group difference 0.29 [95% CI 0.01-0.57]) and ACQ (adjusted difference of -0.33 [95% CI -0.61 to -0.05]) scores in favor of the IG (</offsets><xref ref-type="fig" rid="figure4"><offsets xml_i="29013" xml_f="29022" txt_i="17390" txt_f="17399">Figures 4</offsets></xref><offsets xml_i="29029" xml_f="29034" txt_i="17399" txt_f="17404"> and </offsets><xref ref-type="fig" rid="figure5"><offsets xml_i="29069" xml_f="29070" txt_i="17404" txt_f="17405">5</offsets></xref><offsets xml_i="29077" xml_f="29166" txt_i="17405" txt_f="17494">). No such differences were demonstrated for ICS dosage and lung function measured as FEV</offsets><sub><offsets xml_i="29171" xml_f="29172" txt_i="17494" txt_f="17495">1</offsets></sub><offsets xml_i="29178" xml_f="29180" txt_i="17495" txt_f="17497"> (</offsets><xref ref-type="fig" rid="figure6"><offsets xml_i="29215" xml_f="29224" txt_i="17497" txt_f="17506">Figures 6</offsets></xref><offsets xml_i="29231" xml_f="29236" txt_i="17506" txt_f="17511"> and </offsets><xref ref-type="fig" rid="figure7"><offsets xml_i="29271" xml_f="29272" txt_i="17511" txt_f="17512">7</offsets></xref><offsets xml_i="29279" xml_f="29540" txt_i="17512" txt_f="17773">). Patients with uncontrolled asthma at baseline (ACQ≤0.75) had significant better outcomes at 30 months for AQLQ (adjusted within-group difference of 0.52 [95% CI 0.10-0.95]) and asthma control (adjusted difference -0.44 [95% CI 0.04-0.85]) in favor of the IG.</offsets></p><table-wrap id="table3" position="float"><label><offsets xml_i="29592" xml_f="29599" txt_i="17774" txt_f="17781">Table 3</offsets></label><caption><p><offsets xml_i="29619" xml_f="29644" txt_i="17781" txt_f="17806">Baseline characteristics.</offsets></p></caption><table frame="hsides" rules="groups" width="616" border="0" cellpadding="7" cellspacing="0"><col width="210" span="1"></col><col width="120" span="1"></col><col width="120" span="1"></col><col width="110" span="1"></col><thead><tr valign="top"><td colspan="2" rowspan="1"><offsets xml_i="29930" xml_f="29945" txt_i="17807" txt_f="17822">Characteristics</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29978" xml_f="29993" txt_i="17823" txt_f="17838">Internet group </offsets><break></break><offsets xml_i="30008" xml_f="30013" txt_i="17838" txt_f="17843">
n=47</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30046" xml_f="30063" txt_i="17844" txt_f="17861">Usual care group </offsets><break></break><offsets xml_i="30078" xml_f="30083" txt_i="17861" txt_f="17866">
n=60</offsets></td></tr></thead><tbody><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="30153" xml_f="30167" txt_i="17867" txt_f="17881">Age, mean (SD)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30200" xml_f="30201" txt_i="17882" txt_f="17883">
</offsets><break></break><offsets xml_i="30216" xml_f="30217" txt_i="17883" txt_f="17884">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30250" xml_f="30258" txt_i="17885" txt_f="17893">36 (8.7)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30291" xml_f="30299" txt_i="17894" txt_f="17902">37 (8.0)</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="30354" xml_f="30355" txt_i="17903" txt_f="17904">
</offsets><bold><offsets xml_i="30361" xml_f="30374" txt_i="17904" txt_f="17917">Gender, n (%)</offsets></bold><offsets xml_i="30381" xml_f="30382" txt_i="17917" txt_f="17918">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30415" xml_f="30416" txt_i="17919" txt_f="17920">
</offsets><break></break><offsets xml_i="30431" xml_f="30432" txt_i="17920" txt_f="17921">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30465" xml_f="30466" txt_i="17922" txt_f="17923">
</offsets><break></break><offsets xml_i="30481" xml_f="30482" txt_i="17923" txt_f="17924">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30515" xml_f="30516" txt_i="17925" txt_f="17926">
</offsets><break></break><offsets xml_i="30531" xml_f="30532" txt_i="17926" txt_f="17927">
</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="30587" xml_f="30588" txt_i="17928" txt_f="17929">
</offsets><break></break><offsets xml_i="30603" xml_f="30604" txt_i="17929" txt_f="17930">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30637" xml_f="30641" txt_i="17931" txt_f="17935">Male</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30674" xml_f="30681" txt_i="17936" txt_f="17943">12 (26)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30714" xml_f="30721" txt_i="17944" txt_f="17951">19 (32)</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="30776" xml_f="30777" txt_i="17952" txt_f="17953">
</offsets><break></break><offsets xml_i="30792" xml_f="30793" txt_i="17953" txt_f="17954">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30826" xml_f="30832" txt_i="17955" txt_f="17961">Female</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30865" xml_f="30872" txt_i="17962" txt_f="17969">35 (74)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30905" xml_f="30912" txt_i="17970" txt_f="17977">41 (68)</offsets></td></tr><tr valign="top"><td rowspan="1" colspan="1"><offsets xml_i="30967" xml_f="30981" txt_i="17978" txt_f="17992">Smokers, n (%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31014" xml_f="31015" txt_i="17993" txt_f="17994">
</offsets><break></break><offsets xml_i="31030" xml_f="31031" txt_i="17994" txt_f="17995">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31064" xml_f="31071" txt_i="17996" txt_f="18003">25 (53)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31104" xml_f="31111" txt_i="18004" txt_f="18011">27 (45)</offsets></td></tr><tr valign="top"><td colspan="2" rowspan="1"><offsets xml_i="31166" xml_f="31209" txt_i="18012" txt_f="18055">Inhaled corticosteroids (µg/day), mean (SD)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31242" xml_f="31251" txt_i="18056" txt_f="18065">455 (279)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31284" xml_f="31293" txt_i="18066" txt_f="18075">476 (338)</offsets></td></tr><tr valign="bottom"><td colspan="2" rowspan="1"><offsets xml_i="31351" xml_f="31372" txt_i="18076" txt_f="18097">AQLQ score, mean (SD)</offsets><sup><offsets xml_i="31377" xml_f="31378" txt_i="18097" txt_f="18098">a</offsets></sup><offsets xml_i="31384" xml_f="31385" txt_i="18098" txt_f="18099">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31418" xml_f="31429" txt_i="18100" txt_f="18111">5.88 (0.74)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31462" xml_f="31473" txt_i="18112" txt_f="18123">5.84 (0.82)</offsets></td></tr><tr valign="bottom"><td colspan="2" rowspan="1"><offsets xml_i="31531" xml_f="31552" txt_i="18124" txt_f="18145">ACQ score , mean (SD)</offsets><sup><offsets xml_i="31557" xml_f="31558" txt_i="18145" txt_f="18146">b</offsets></sup><offsets xml_i="31564" xml_f="31565" txt_i="18146" txt_f="18147">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31598" xml_f="31609" txt_i="18148" txt_f="18159">0.93 (0.60)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31642" xml_f="31653" txt_i="18160" txt_f="18171">0.97 (0.65)</offsets></td></tr><tr valign="bottom"><td colspan="2" rowspan="1"><offsets xml_i="31711" xml_f="31732" txt_i="18172" txt_f="18193">Prebronchodilator FEV</offsets><sub><offsets xml_i="31737" xml_f="31738" txt_i="18193" txt_f="18194">1</offsets></sub><offsets xml_i="31744" xml_f="31755" txt_i="18194" txt_f="18205">, mean (SD)</offsets><sup><offsets xml_i="31760" xml_f="31761" txt_i="18205" txt_f="18206">c</offsets></sup><offsets xml_i="31767" xml_f="31768" txt_i="18206" txt_f="18207">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31801" xml_f="31812" txt_i="18208" txt_f="18219">3.26 (0.80)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31845" xml_f="31856" txt_i="18220" txt_f="18231">3.41 (0.96)</offsets></td></tr><tr valign="bottom"><td colspan="2" rowspan="1"><offsets xml_i="31914" xml_f="31935" txt_i="18232" txt_f="18253">Prebronchodilator FEV</offsets><sub><offsets xml_i="31940" xml_f="31941" txt_i="18253" txt_f="18254">1</offsets></sub><offsets xml_i="31947" xml_f="31972" txt_i="18254" txt_f="18279"> (% predicted), mean (SD)</offsets><sup><offsets xml_i="31977" xml_f="31978" txt_i="18279" txt_f="18280">c</offsets></sup><offsets xml_i="31984" xml_f="31985" txt_i="18280" txt_f="18281">
</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32018" xml_f="32027" txt_i="18282" txt_f="18291">96.8 (20)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32060" xml_f="32069" txt_i="18292" txt_f="18301">95.5 (18)</offsets></td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><offsets xml_i="32134" xml_f="32135" txt_i="18302" txt_f="18303">
</offsets><sup><offsets xml_i="32140" xml_f="32141" txt_i="18303" txt_f="18304">a</offsets></sup><offsets xml_i="32147" xml_f="32228" txt_i="18304" txt_f="18385">Score range (worst-best), 1-7; minimal clinical important difference (MCID): 0.5.</offsets></p></fn><fn id="table3fn2"><p><offsets xml_i="32259" xml_f="32260" txt_i="18386" txt_f="18387">
</offsets><sup><offsets xml_i="32265" xml_f="32266" txt_i="18387" txt_f="18388">b</offsets></sup><offsets xml_i="32272" xml_f="32313" txt_i="18388" txt_f="18429">Score range (worst-best), 6-0; MCID: 0.5.</offsets></p></fn><fn id="table3fn3"><p><offsets xml_i="32344" xml_f="32345" txt_i="18430" txt_f="18431">
</offsets><sup><offsets xml_i="32350" xml_f="32351" txt_i="18431" txt_f="18432">c</offsets></sup><offsets xml_i="32357" xml_f="32449" txt_i="18432" txt_f="18524">Number of available observations in the Internet group is 26 and in the usual care group 37.</offsets></p></fn></table-wrap-foot></table-wrap><fig id="figure3" position="float"><label><offsets xml_i="32531" xml_f="32539" txt_i="18525" txt_f="18533">Figure 3</offsets></label><caption><p><offsets xml_i="32559" xml_f="32591" txt_i="18533" txt_f="18565">Flowchart of study participants.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig3"></graphic></fig><fig id="figure4" position="float"><label><offsets xml_i="32705" xml_f="32713" txt_i="18566" txt_f="18574">Figure 4</offsets></label><caption><p><offsets xml_i="32733" xml_f="32871" txt_i="18574" txt_f="18712">Mean Asthma Quality of Life Questionnaire score for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig4"></graphic></fig><fig id="figure5" position="float"><label><offsets xml_i="32985" xml_f="32993" txt_i="18713" txt_f="18721">Figure 5</offsets></label><caption><p><offsets xml_i="33013" xml_f="33143" txt_i="18721" txt_f="18851">Mean Asthma Control Questionnaire score for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig5"></graphic></fig><fig id="figure6" position="float"><label><offsets xml_i="33257" xml_f="33265" txt_i="18852" txt_f="18860">Figure 6</offsets></label><caption><p><offsets xml_i="33285" xml_f="33391" txt_i="18860" txt_f="18966">Mean ICS dosage for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig6"></graphic></fig><fig id="figure7" position="float"><label><offsets xml_i="33505" xml_f="33513" txt_i="18967" txt_f="18975">Figure 7</offsets></label><caption><p><offsets xml_i="33533" xml_f="33633" txt_i="18975" txt_f="19075">Mean FEV1 for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.</offsets></p></caption><graphic xlink:href="jmir_v15i9e188_fig7"></graphic></fig></sec></sec><sec sec-type="discussion"><title><offsets xml_i="33751" xml_f="33761" txt_i="19078" txt_f="19088">Discussion</offsets></title><sec><title><offsets xml_i="33781" xml_f="33799" txt_i="19089" txt_f="19107">Principal Findings</offsets></title><p><offsets xml_i="33810" xml_f="34363" txt_i="19108" txt_f="19661">This study indicates that provision of IBSM support for 1 year leads to sustained benefits in terms of asthma control and asthma-related quality of life as compared with usual care, even up to 1.5 years after terminating support. IBSM support was additional to usual care and consisted of education, an action plan, self-monitoring, and regular medical review. Therefore, this study illustrates that sustained health improvements in health can be achieved by a structured care approach and self-management support as outlined by the Chronic Care model [</offsets><xref ref-type="bibr" rid="ref23"><offsets xml_i="34397" xml_f="34399" txt_i="19661" txt_f="19663">23</offsets></xref><offsets xml_i="34406" xml_f="34603" txt_i="19663" txt_f="19860">]. To our knowledge, this is the first study on long-term outcomes of Internet-based comprehensive self-management delivered to patients with asthma in primary care. In the study by Thoonen et al [</offsets><xref ref-type="bibr" rid="ref27"><offsets xml_i="34637" xml_f="34639" txt_i="19860" txt_f="19862">27</offsets></xref><offsets xml_i="34646" xml_f="34903" txt_i="19862" txt_f="20119">], it was demonstrated that guided self-management to patients with asthma in Dutch general practice for 2 years leads to small but sustained benefits in asthma control (except for lung function) and asthma-related quality of life as compared to usual care.</offsets></p></sec><sec><title><offsets xml_i="34925" xml_f="34936" txt_i="20121" txt_f="20132">Limitations</offsets></title><p><offsets xml_i="34947" xml_f="35045" txt_i="20133" txt_f="20231">The original SMASHING study had several strengths, which have been discussed at length elsewhere [</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="35079" xml_f="35081" txt_i="20231" txt_f="20233">15</offsets></xref><offsets xml_i="35088" xml_f="35266" txt_i="20233" txt_f="20411">]. Briefly, the study had a strong randomized controlled design without major baseline differences between patients in both groups and was characterized by a pragmatic attitude [</offsets><xref ref-type="bibr" rid="ref28"><offsets xml_i="35300" xml_f="35302" txt_i="20411" txt_f="20413">28</offsets></xref><offsets xml_i="35309" xml_f="35495" txt_i="20413" txt_f="20599">]. Nevertheless, results of this follow-up measurement need to be interpreted with some caution. First, our response rate was relatively low compared to other long-term outcome studies [</offsets><xref ref-type="bibr" rid="ref29"><offsets xml_i="35529" xml_f="35531" txt_i="20599" txt_f="20601">29</offsets></xref><offsets xml_i="35538" xml_f="36202" txt_i="20601" txt_f="21265">], which might limit the generalizability of our results. Second, even though a sustained effect for both asthma control and asthma-related quality of life in favor of the IG was demonstrated, these differences did not reach the threshold of a clinical important difference (MCID). However, we included patients with well-controlled asthma at baseline. In contrast, the subgroup of patients with uncontrolled asthma at baseline did show a clinical relevant difference in terms of asthma-related quality of life. Patients with worse asthma control have a larger room for improvement and could therefore be more willing to participate in self-management activities [</offsets><xref ref-type="bibr" rid="ref30"><offsets xml_i="36236" xml_f="36238" txt_i="21265" txt_f="21267">30</offsets></xref><offsets xml_i="36245" xml_f="36247" txt_i="21267" txt_f="21269">].</offsets></p><p><offsets xml_i="36254" xml_f="36720" txt_i="21270" txt_f="21736">Even though IG patients had better outcomes in terms of asthma control and asthma-related quality of life as compared with UC patients, this difference was not accompanied with a higher ICS dosage for IG patients. Whether this can be attributed to the ability of the individual IG patient to tailor treatment to his or her need remains unclear. Moreover, the propensity to change in-treatment steps could have been reduced as guidance by IBSM support was terminated.</offsets></p><p><offsets xml_i="36727" xml_f="37384" txt_i="21737" txt_f="22394">To what extent demonstrated long-term benefits can be attributed to the mode of delivery, beyond incorporating components (education, monitoring, action plan, and regular review) for effective self-management, remains unclear. More specifically, whether the IBSM approach has led to improved self-management skills can only be postulated as we did not collect data on self-management outcomes, such as self-efficacy or compliance. If self-management skills have been improved, this is due to more intensive support in the start-up phase, since at 12 months after baseline only about 60% of the patients were still using the program on their own initiative [</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="37418" xml_f="37420" txt_i="22394" txt_f="22396">16</offsets></xref><offsets xml_i="37427" xml_f="37633" txt_i="22396" txt_f="22602">]. This illustrates that patients do not seem to develop dependence on modern technology, a known barrier for both patients and professionals for using modern technology for asthma self-management support [</offsets><xref ref-type="bibr" rid="ref31"><offsets xml_i="37667" xml_f="37669" txt_i="22602" txt_f="22604">31</offsets></xref><offsets xml_i="37676" xml_f="37914" txt_i="22604" txt_f="22842">]. Moreover, it also suggests that intensity of a self-management support program should be tailored to the individual patient; once a patient has met his or her personal objective, the intensity should be adjusted. Recently, Ryan et al [</offsets><xref ref-type="bibr" rid="ref32"><offsets xml_i="37948" xml_f="37950" txt_i="22842" txt_f="22844">32</offsets></xref><offsets xml_i="37957" xml_f="38780" txt_i="22844" txt_f="23667">] compared a comprehensive self-management approach for adults with poorly controlled asthma (ACQ≥1.5) in general practice in which the monitoring module was either paper-based or mobile phone-based. After 6 months follow-up, both patient groups had improved in terms of asthma control and self-efficacy, but no difference was demonstrated between groups. Clearly, this study does illustrate that there is room for improvement in provision of routine asthma care, since in both groups self-management was delivered in concordance with asthma guidelines (consisting of education, self-monitoring, action plan, and guidance by a professional). Nevertheless, this does not imply that modern technology might not be important since it does offer opportunities to enhance adoption of self-management support within routine care.</offsets></p></sec><sec><title><offsets xml_i="38802" xml_f="38813" txt_i="23669" txt_f="23680">Conclusions</offsets></title><p><offsets xml_i="38824" xml_f="39044" txt_i="23681" txt_f="23901">From a patient perspective, there is an increasing demand to use modern technology in the management of chronic disease. In asthma, this is illustrated by a growing number of available apps for asthma “self-management” [</offsets><xref ref-type="bibr" rid="ref33"><offsets xml_i="39078" xml_f="39080" txt_i="23901" txt_f="23903">33</offsets></xref><offsets xml_i="39087" xml_f="39244" txt_i="23903" txt_f="24060">]. Unfortunately, these apps are characterized not only by their lack of all components for effective self-management but also by a lack of reliable content.</offsets></p><p><offsets xml_i="39251" xml_f="39545" txt_i="24061" txt_f="24355">Given the sustained benefits, cost-effectiveness becomes more favorable for IBSM, since major intervention costs, such as equipment and education sessions, apply to the first year, while maintenance costs can be spread over a longer period and could be improved by an increased number of users.</offsets></p><p><offsets xml_i="39552" xml_f="39715" txt_i="24356" txt_f="24519">For successful adoption of IBSM within routine care and into a patient’s daily life, several preconditions need to be identified and addressed among stakeholders [</offsets><xref ref-type="bibr" rid="ref34"><offsets xml_i="39749" xml_f="39751" txt_i="24519" txt_f="24521">34</offsets></xref><offsets xml_i="39758" xml_f="39759" txt_i="24521" txt_f="24522">,</offsets><xref ref-type="bibr" rid="ref35"><offsets xml_i="39793" xml_f="39795" txt_i="24522" txt_f="24524">35</offsets></xref><offsets xml_i="39802" xml_f="40726" txt_i="24524" txt_f="25448">]. For instance, IBSM support should address daily routines of patients, for example, frequency of monitoring should be able to be adjusted to the needs of the individual patient. From an organizational point of view, an adequate infrastructure for asthma care (eg, routine consultations) should be available within practices. Moreover, technology should be integrated within the current available digital infrastructure. At a professional level, (Internet-based) self-management support requires a proactive role from the health care provider, which allows for a patient-professional partnership. Finally, from an economic point of view, financial incentives such as adequate reimbursements of lung function meters and consultations by health care insurance companies could be considered. More research is needed on the question of how to embed self-management support by means of modern technology within routine practice.</offsets></p><p><offsets xml_i="40733" xml_f="41194" txt_i="25449" txt_f="25910">A comprehensive Internet-based self-management approach leads to sustained benefits in terms of asthma-related quality of life and asthma control, even up to 1.5 years after terminating support, particularly for patients with asthma that was not well controlled at baseline. Future research is needed to gain insight on long-term outcomes, cost-effectiveness, and strategies for integration of self-management support by modern technology in real-life settings.</offsets></p></sec></sec></body><back><ack><p>This study was supported by grants from the Netherlands Organization for Health Research and Development (Zon-MW) and the Lung Foundation Netherlands. Funding for this publication was obtained from the Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access publications. The SMASHING (Self-Management of Asthma Support by Hospitals, ICT, Nurses and General practitioners) Study Group consisted of WJJ Assendelft, MD, PhD; MJ Bakker, RN; EH Bel, MD, PhD; SB Detmar, PhD; JC de Jongste, MD, PhD; AA Kaptein, PhD; V van der Meer, MD, PhD; KF Rabe, MD, PhD; ERVM Rikkers-Mutsaerts, MD; JK Sont, PhD; HF van Stel, PhD; PJ Sterk, PhD; HA Thiadens, MD, PhD; PJ Toussaint, PhD. We thank professor EF Juniper for the permission to use a Web-based version of the Asthma Control Questionnaire.</p></ack><fn-group><fn fn-type="con"><p>Authors' Contributions: VM, MB, and JKS were involved in the design of the study. VM, MB, PR, WR, and TB contributed to data acquisition. VM and MB guided patients in Internet-based self-management support. JG, TB, PR, WR, and JKS contributed to data analysis. JG and JKS drafted the manuscript, which was critically revised by all authors. The manuscript has been read and been approved by all authors.</p></fn><fn fn-type="conflict"><p>Conflicts of Interest: None declared.</p></fn></fn-group><app-group><app id="app1"><title>Multimedia Appendix 1</title><p>CONSORT-EHEALTH checklist V1.6.2 [<xref ref-type="bibr" rid="ref21">21</xref>].</p><fig id="d35e977" position="anchor"><media xlink:href="jmir_v15i9e188_app1.pdf"></media></fig></app><app id="app2"><title>Multimedia Appendix 2</title><p>Screenshots of the original SMASHING website: website functionalities and daily symptom/lung function monitoring; weekly symptom monitoring by using the 7-item Asthma Control Questionnaire; and feedback on symptoms and lung function monitoring.</p><fig id="d35e983" position="anchor"><media xlink:href="jmir_v15i9e188_app2.pptx"></media></fig></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">ACQ</term><def><p>asthma control questionnaire</p></def></def-item><def-item><term id="abb2">AQLQ</term><def><p>asthma-related quality of life questionnaire</p></def></def-item><def-item><term id="abb3">FEV1</term><def><p>forced expiratory volume in one second</p></def></def-item><def-item><term id="abb4">GINA</term><def><p>Global Initiative for Asthma</p></def></def-item><def-item><term id="abb5">IBSM</term><def><p>Internet-based self-management</p></def></def-item><def-item><term id="abb6">ICS</term><def><p>inhaled corticosteroids</p></def></def-item><def-item><term id="abb7">IG</term><def><p>Internet group</p></def></def-item><def-item><term id="abb8">MCID</term><def><p>minimal clinical important difference</p></def></def-item><def-item><term id="abb9">RN</term><def><p>respiratory nurse</p></def></def-item><def-item><term id="abb10">SMASHING</term><def><p>Self-Management in Asthma Supported by Hospitals, ICT, Nurses and General practitioners</p></def></def-item><def-item><term id="abb11">UC</term><def><p>usual care</p></def></def-item></def-list></glossary><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demoly</surname><given-names>P</given-names></name><name><surname>Paggiaro</surname><given-names>P</given-names></name><name><surname>Plaza</surname><given-names>V</given-names></name><name><surname>Bolge</surname><given-names>SC</given-names></name><name><surname>Kannan</surname><given-names>H</given-names></name><name><surname>Sohier</surname><given-names>B</given-names></name><name><surname>Adamek</surname><given-names>L</given-names></name></person-group><article-title>Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK</article-title><source>Eur Respir Rev</source><year>2009</year><month>6</month><volume>18</volume><issue>112</issue><fpage>105</fpage><lpage>12</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://err.ersjournals.com/cgi/pmidlookup?view=long&amp;pmid=20956130"></ext-link></comment><pub-id pub-id-type="doi">10.1183/09059180.00001209</pub-id><pub-id pub-id-type="medline">20956130</pub-id><pub-id pub-id-type="pmid">20956130</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>British Thoracic Society</collab><collab>Scottish Intercollegiate Guidelines Network</collab></person-group><source>British guideline on the management of asthma</source><year>2008</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.brit-thoracic.org.uk/Portals/0/Guidelines/AsthmaGuidelines/sign101%20Jan%202012.pdf.Archived">http://www.brit-thoracic.org.uk/Portals/0/Guidelines/AsthmaGuidelines/sign101%20Jan%202012.pdf.Archived</ext-link></comment><ext-link ext-link-type="webcite" xlink:href="6Dps9ca6A"></ext-link></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Global Initiative for Asthma (GINA)</collab></person-group><source>Global strategy for asthma management and prevention</source><year>2012</year><date-in-citation>2013-01-21</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.ginasthma.org/uploads/users/files/GINA_Report_2012.pdf">http://www.ginasthma.org/uploads/users/files/GINA_Report_2012.pdf</ext-link></comment><ext-link ext-link-type="webcite" xlink:href="6DpsUFKEa"></ext-link></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabe</surname><given-names>KF</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>CK</given-names></name><name><surname>Soriano</surname><given-names>JB</given-names></name><name><surname>Vermeire</surname><given-names>PA</given-names></name><name><surname>Weiss</surname><given-names>KB</given-names></name><name><surname>Weiss</surname><given-names>ST</given-names></name></person-group><article-title>Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys</article-title><source>J Allergy Clin Immunol</source><year>2004</year><month>7</month><volume>114</volume><issue>1</issue><fpage>40</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2004.04.042</pub-id><pub-id pub-id-type="medline">15241342</pub-id><pub-id pub-id-type="pmid">15241342</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>PG</given-names></name><name><surname>Powell</surname><given-names>H</given-names></name><name><surname>Coughlan</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>AJ</given-names></name><name><surname>Abramson</surname><given-names>M</given-names></name><name><surname>Haywood</surname><given-names>P</given-names></name><name><surname>Bauman</surname><given-names>A</given-names></name><name><surname>Hensley</surname><given-names>MJ</given-names></name><name><surname>Walters</surname><given-names>EH</given-names></name></person-group><article-title>Self-management education and regular practitioner review for adults with asthma</article-title><source>Cochrane Database Syst Rev</source><year>2003</year><issue>1</issue><fpage>CD001117</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD001117</pub-id><pub-id pub-id-type="medline">12535399</pub-id><pub-id pub-id-type="pmid">12535399</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskins</surname><given-names>G</given-names></name><name><surname>McCowan</surname><given-names>C</given-names></name><name><surname>Donnan</surname><given-names>PT</given-names></name><name><surname>Friend</surname><given-names>JA</given-names></name><name><surname>Osman</surname><given-names>LM</given-names></name><collab>Asthma UK Scotland</collab><collab>Scottish Executive Health Department</collab></person-group><article-title>Results of a national asthma campaign survey of primary care in Scotland</article-title><source>Int J Qual Health Care</source><year>2005</year><month>6</month><volume>17</volume><issue>3</issue><fpage>209</fpage><lpage>15</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://intqhc.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=15831548"></ext-link></comment><pub-id pub-id-type="doi">10.1093/intqhc/mzi036</pub-id><pub-id pub-id-type="medline">15831548</pub-id><pub-id pub-id-type="pmid">15831548</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiener-Ogilvie</surname><given-names>S</given-names></name><name><surname>Pinnock</surname><given-names>H</given-names></name><name><surname>Huby</surname><given-names>G</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name><name><surname>Partridge</surname><given-names>MR</given-names></name><name><surname>Gillies</surname><given-names>J</given-names></name></person-group><article-title>Do practices comply with key recommendations of the British Asthma Guideline? If not, why not?</article-title><source>Prim Care Respir J</source><year>2007</year><month>12</month><volume>16</volume><issue>6</issue><fpage>369</fpage><lpage>77</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3132/pcrj.2007.00074"></ext-link></comment><pub-id pub-id-type="doi">10.3132/pcrj.2007.00074</pub-id><pub-id pub-id-type="medline">18026674</pub-id><pub-id pub-id-type="pmid">18026674</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Australian Centre for Asthma Monitoring</collab></person-group><source>Asthma in Australia 2011</source><date-in-citation>2013-01-21</date-in-citation><publisher-name>The Australian Institute of Health and Welfare (AIHW)</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737420155">http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737420155</ext-link></comment><ext-link ext-link-type="webcite" xlink:href="6DpuKzbXE"></ext-link></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ring</surname><given-names>N</given-names></name><name><surname>Jepson</surname><given-names>R</given-names></name><name><surname>Hoskins</surname><given-names>G</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Pinnock</surname><given-names>H</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name><name><surname>Wyke</surname><given-names>S</given-names></name></person-group><article-title>Understanding what helps or hinders asthma action plan use: a systematic review and synthesis of the qualitative literature</article-title><source>Patient Educ Couns</source><year>2011</year><month>11</month><volume>85</volume><issue>2</issue><fpage>e131</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2011.01.025</pub-id><pub-id pub-id-type="medline">21396793</pub-id><pub-id pub-id-type="pmid">21396793</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>S</given-names></name><name><surname>Brinke</surname><given-names>AT</given-names></name><name><surname>Roldaan</surname><given-names>AC</given-names></name><name><surname>van Veen</surname><given-names>IH</given-names></name><name><surname>Möller</surname><given-names>GM</given-names></name><name><surname>Sont</surname><given-names>JK</given-names></name><name><surname>Weersink</surname><given-names>EJ</given-names></name><name><surname>van der Zee</surname><given-names>JS</given-names></name><name><surname>Braunstahl</surname><given-names>GJ</given-names></name><name><surname>Zwinderman</surname><given-names>AH</given-names></name><name><surname>Sterk</surname><given-names>PJ</given-names></name><name><surname>Bel</surname><given-names>EH</given-names></name></person-group><article-title>Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial</article-title><source>Thorax</source><year>2011</year><month>6</month><volume>66</volume><issue>6</issue><fpage>514</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1136/thx.2010.153411</pub-id><pub-id pub-id-type="medline">21474498</pub-id><pub-id pub-id-type="pmid">21474498</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WT</given-names></name><name><surname>Huang</surname><given-names>CD</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Lin</surname><given-names>SM</given-names></name><name><surname>Kuo</surname><given-names>HP</given-names></name></person-group><article-title>A mobile telephone-based interactive self-care system improves asthma control</article-title><source>Eur Respir J</source><year>2011</year><month>2</month><volume>37</volume><issue>2</issue><fpage>310</fpage><lpage>7</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://erj.ersjournals.com/cgi/pmidlookup?view=long&amp;pmid=20562122"></ext-link></comment><pub-id pub-id-type="doi">10.1183/09031936.00000810</pub-id><pub-id pub-id-type="medline">20562122</pub-id><pub-id pub-id-type="pmid">20562122</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>S</given-names></name><name><surname>Chandler</surname><given-names>D</given-names></name><name><surname>Nurmatov</surname><given-names>U</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Pagliari</surname><given-names>C</given-names></name><name><surname>Car</surname><given-names>J</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name></person-group><article-title>Telehealthcare for asthma: a Cochrane review</article-title><source>CMAJ</source><year>2011</year><month>8</month><day>9</day><volume>183</volume><issue>11</issue><fpage>E733</fpage><lpage>42</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.cmaj.ca/cgi/pmidlookup?view=long&amp;pmid=21746825"></ext-link></comment><pub-id pub-id-type="doi">10.1503/cmaj.101146</pub-id><pub-id pub-id-type="medline">21746825</pub-id><pub-id pub-id-type="pmid">21746825</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araújo</surname><given-names>L</given-names></name><name><surname>Jacinto</surname><given-names>T</given-names></name><name><surname>Moreira</surname><given-names>A</given-names></name><name><surname>Castel-Branco</surname><given-names>MG</given-names></name><name><surname>Delgado</surname><given-names>L</given-names></name><name><surname>Costa-Pereira</surname><given-names>A</given-names></name><name><surname>Fonseca</surname><given-names>J</given-names></name></person-group><article-title>Clinical efficacy of web-based versus standard asthma self-management</article-title><source>J Investig Allergol Clin Immunol</source><year>2012</year><volume>22</volume><issue>1</issue><fpage>28</fpage><lpage>34</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.jiaci.org/issues/vol22issue1/vol22issue01-4.htm"></ext-link></comment><pub-id pub-id-type="medline">22448451</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Sickle</surname><given-names>D</given-names></name><name><surname>Magzamen</surname><given-names>S</given-names></name><name><surname>Truelove</surname><given-names>S</given-names></name><name><surname>Morrison</surname><given-names>T</given-names></name></person-group><article-title>Remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma control</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>2</issue><fpage>e55335</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.plos.org/10.1371/journal.pone.0055335"></ext-link></comment><pub-id pub-id-type="doi">10.1371/journal.pone.0055335</pub-id><pub-id pub-id-type="medline">23460785</pub-id><pub-id pub-id-type="pmid">23460785</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meer</surname><given-names>V</given-names></name><name><surname>Bakker</surname><given-names>MJ</given-names></name><name><surname>van den Hout</surname><given-names>WB</given-names></name><name><surname>Rabe</surname><given-names>KF</given-names></name><name><surname>Sterk</surname><given-names>PJ</given-names></name><name><surname>Kievit</surname><given-names>J</given-names></name><name><surname>Assendelft</surname><given-names>WJ</given-names></name><name><surname>Sont</surname><given-names>JK</given-names></name><collab>SMASHING (Self-Management in Asthma Supported by Hospitals‚ ICT‚ Nurses and General Practitioners) Study Group</collab></person-group><article-title>Internet-based self-management plus education compared with usual care in asthma: a randomized trial</article-title><source>Ann Intern Med</source><year>2009</year><month>7</month><day>21</day><volume>151</volume><issue>2</issue><fpage>110</fpage><lpage>20</lpage><pub-id pub-id-type="medline">19620163</pub-id><pub-id pub-id-type="pmid">19620163</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meer</surname><given-names>V</given-names></name><name><surname>van Stel</surname><given-names>HF</given-names></name><name><surname>Bakker</surname><given-names>MJ</given-names></name><name><surname>Roldaan</surname><given-names>AC</given-names></name><name><surname>Assendelft</surname><given-names>WJ</given-names></name><name><surname>Sterk</surname><given-names>PJ</given-names></name><name><surname>Rabe</surname><given-names>KF</given-names></name><name><surname>Sont</surname><given-names>JK</given-names></name><collab>SMASHING (Self-Management of Asthma Supported by Hospitals‚ ICT‚ Nurses and General practitioners) Study Group</collab></person-group><article-title>Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study</article-title><source>Respir Res</source><year>2010</year><volume>11</volume><fpage>74</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://respiratory-research.com/content/11//74"></ext-link></comment><pub-id pub-id-type="doi">10.1186/1465-9921-11-74</pub-id><pub-id pub-id-type="medline">20537124</pub-id><pub-id pub-id-type="pmid">20537124</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juniper</surname><given-names>EF</given-names></name></person-group><article-title>Assessing asthma control</article-title><source>Curr Allergy Asthma Rep</source><year>2007</year><month>9</month><volume>7</volume><issue>5</issue><fpage>390</fpage><lpage>4</lpage><pub-id pub-id-type="medline">17697649</pub-id><pub-id pub-id-type="pmid">17697649</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juniper</surname><given-names>EF</given-names></name><name><surname>Bousquet</surname><given-names>J</given-names></name><name><surname>Abetz</surname><given-names>L</given-names></name><name><surname>Bateman</surname><given-names>ED</given-names></name><collab>GOAL Committee</collab></person-group><article-title>Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire</article-title><source>Respir Med</source><year>2006</year><month>4</month><volume>100</volume><issue>4</issue><fpage>616</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2005.08.012</pub-id><pub-id pub-id-type="medline">16226443</pub-id><pub-id pub-id-type="pmid">16226443</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juniper</surname><given-names>EF</given-names></name><name><surname>Buist</surname><given-names>AS</given-names></name><name><surname>Cox</surname><given-names>FM</given-names></name><name><surname>Ferrie</surname><given-names>PJ</given-names></name><name><surname>King</surname><given-names>DR</given-names></name></person-group><article-title>Validation of a standardized version of the Asthma Quality of Life Questionnaire</article-title><source>Chest</source><year>1999</year><month>5</month><volume>115</volume><issue>5</issue><fpage>1265</fpage><lpage>70</lpage><pub-id pub-id-type="medline">10334138</pub-id><pub-id pub-id-type="pmid">10334138</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Medical Association (WMA)</collab></person-group><source>Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects</source><year>2008</year><date-in-citation>2013-01-21</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.wma.net/en/30publications/10policies/b3/">http://www.wma.net/en/30publications/10policies/b3/</ext-link></comment><ext-link ext-link-type="webcite" xlink:href="6DpuvsW52"></ext-link></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eysenbach</surname><given-names>G</given-names></name><collab>CONSORT-EHEALTH Group</collab></person-group><article-title>CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions</article-title><source>J Med Internet Res</source><year>2011</year><volume>13</volume><issue>4</issue><fpage>e126</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.jmir.org/2011/4/e126/"></ext-link></comment><pub-id pub-id-type="doi">10.2196/jmir.1923</pub-id><pub-id pub-id-type="medline">22209829</pub-id><pub-id pub-id-type="pmid">22209829</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meer</surname><given-names>V</given-names></name><name><surname>van Stel</surname><given-names>HF</given-names></name><name><surname>Detmar</surname><given-names>SB</given-names></name><name><surname>Otten</surname><given-names>W</given-names></name><name><surname>Sterk</surname><given-names>PJ</given-names></name><name><surname>Sont</surname><given-names>JK</given-names></name></person-group><article-title>Internet-based self-management offers an opportunity to achieve better asthma control in adolescents</article-title><source>Chest</source><year>2007</year><month>7</month><volume>132</volume><issue>1</issue><fpage>112</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1378/chest.06-2787</pub-id><pub-id pub-id-type="medline">17400674</pub-id><pub-id pub-id-type="pmid">17400674</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>K</given-names></name><name><surname>Austin</surname><given-names>BT</given-names></name><name><surname>Brach</surname><given-names>C</given-names></name><name><surname>Wagner</surname><given-names>EH</given-names></name></person-group><article-title>Evidence on the Chronic Care Model in the new millennium</article-title><source>Health Aff (Millwood)</source><year>2009</year><volume>28</volume><issue>1</issue><fpage>75</fpage><lpage>85</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://content.healthaffairs.org/cgi/pmidlookup?view=long&amp;pmid=19124857"></ext-link></comment><pub-id pub-id-type="doi">10.1377/hlthaff.28.1.75</pub-id><pub-id pub-id-type="medline">19124857</pub-id><pub-id pub-id-type="pmid">19124857</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Geijer</surname><given-names>RMM</given-names></name><name><surname>Chavannes</surname><given-names>NH</given-names></name><name><surname>Muris</surname><given-names>JWM</given-names></name><name><surname>Sachs</surname><given-names>APE</given-names></name><name><surname>Schermer</surname><given-names>T</given-names></name><name><surname>Smeele</surname><given-names>IJM</given-names></name><name><surname>Thoonen</surname><given-names>B</given-names></name><name><surname>Van der Molen</surname><given-names>T</given-names></name><name><surname>Van Schayck</surname><given-names>CP</given-names></name><name><surname>Van Weel</surname><given-names>C</given-names></name><name><surname>Kolnaar</surname><given-names>BGM</given-names></name><name><surname>Grol</surname><given-names>MH</given-names></name></person-group><source>NHG-Standaard Astma bij volwassenen (Tweede herziening)</source><year>2007</year><date-in-citation>2013-01-21</date-in-citation><publisher-name>The Dutch College of General Practitioners (NHG)</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://nhg.artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/NHGStandaard/M27_std.htm">http://nhg.artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/NHGStandaard/M27_std.htm</ext-link></comment><ext-link ext-link-type="webcite" xlink:href="6DptfyYds"></ext-link></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juniper</surname><given-names>EF</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Willan</surname><given-names>A</given-names></name><name><surname>Griffith</surname><given-names>LE</given-names></name></person-group><article-title>Determining a minimal important change in a disease-specific Quality of Life Questionnaire</article-title><source>J Clin Epidemiol</source><year>1994</year><month>1</month><volume>47</volume><issue>1</issue><fpage>81</fpage><lpage>7</lpage><pub-id pub-id-type="medline">8283197</pub-id><pub-id pub-id-type="pmid">8283197</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juniper</surname><given-names>EF</given-names></name><name><surname>Svensson</surname><given-names>K</given-names></name><name><surname>Mörk</surname><given-names>AC</given-names></name><name><surname>Ståhl</surname><given-names>E</given-names></name></person-group><article-title>Measurement properties and interpretation of three shortened versions of the asthma control questionnaire</article-title><source>Respir Med</source><year>2005</year><month>5</month><volume>99</volume><issue>5</issue><fpage>553</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2004.10.008</pub-id><pub-id pub-id-type="medline">15823451</pub-id><pub-id pub-id-type="pmid">15823451</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoonen</surname><given-names>BP</given-names></name><name><surname>Schermer</surname><given-names>TR</given-names></name><name><surname>Van Den Boom</surname><given-names>G</given-names></name><name><surname>Molema</surname><given-names>J</given-names></name><name><surname>Folgering</surname><given-names>H</given-names></name><name><surname>Akkermans</surname><given-names>RP</given-names></name><name><surname>Grol</surname><given-names>R</given-names></name><name><surname>Van Weel</surname><given-names>C</given-names></name><name><surname>Van Schayck</surname><given-names>CP</given-names></name></person-group><article-title>Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial</article-title><source>Thorax</source><year>2003</year><month>1</month><volume>58</volume><issue>1</issue><fpage>30</fpage><lpage>6</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://thorax.bmj.com/cgi/pmidlookup?view=long&amp;pmid=12511716"></ext-link></comment><pub-id pub-id-type="medline">12511716</pub-id><pub-id pub-id-type="pmid">12511716</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwarenstein</surname><given-names>M</given-names></name><name><surname>Treweek</surname><given-names>S</given-names></name><name><surname>Gagnier</surname><given-names>JJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Tunis</surname><given-names>S</given-names></name><name><surname>Haynes</surname><given-names>B</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><collab>CONSORT group</collab><collab>Pragmatic Trials in Healthcare (Practihc) group</collab></person-group><article-title>Improving the reporting of pragmatic trials: an extension of the CONSORT statement</article-title><source>BMJ</source><year>2008</year><volume>337</volume><fpage>a2390</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.bmj.com/cgi/pmidlookup?view=long&amp;pmid=19001484"></ext-link></comment><pub-id pub-id-type="medline">19001484</pub-id><pub-id pub-id-type="pmid">19001484</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khunti</surname><given-names>K</given-names></name><name><surname>Gray</surname><given-names>LJ</given-names></name><name><surname>Skinner</surname><given-names>T</given-names></name><name><surname>Carey</surname><given-names>ME</given-names></name><name><surname>Realf</surname><given-names>K</given-names></name><name><surname>Dallosso</surname><given-names>H</given-names></name><name><surname>Fisher</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>M</given-names></name><name><surname>Heller</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name></person-group><article-title>Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care</article-title><source>BMJ</source><year>2012</year><volume>344</volume><fpage>e2333</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.bmj.com/cgi/pmidlookup?view=long&amp;pmid=22539172"></ext-link></comment><pub-id pub-id-type="medline">22539172</pub-id><pub-id pub-id-type="pmid">22539172</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khunti</surname><given-names>K</given-names></name><name><surname>Gray</surname><given-names>LJ</given-names></name><name><surname>Skinner</surname><given-names>T</given-names></name><name><surname>Carey</surname><given-names>ME</given-names></name><name><surname>Realf</surname><given-names>K</given-names></name><name><surname>Dallosso</surname><given-names>H</given-names></name><name><surname>Fisher</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>M</given-names></name><name><surname>Heller</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name></person-group><article-title>Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care</article-title><source>BMJ</source><year>2012</year><volume>344</volume><fpage>e2333</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.bmj.com/cgi/pmidlookup?view=long&amp;pmid=22539172"></ext-link></comment><pub-id pub-id-type="medline">22539172</pub-id><pub-id pub-id-type="pmid">22539172</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinnock</surname><given-names>H</given-names></name><name><surname>Slack</surname><given-names>R</given-names></name><name><surname>Pagliari</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name></person-group><article-title>Understanding the potential role of mobile phone-based monitoring on asthma self-management: qualitative study</article-title><source>Clin Exp Allergy</source><year>2007</year><month>5</month><volume>37</volume><issue>5</issue><fpage>794</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.2007.02708.x</pub-id><pub-id pub-id-type="medline">17456228</pub-id><pub-id pub-id-type="pmid">17456228</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>D</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><name><surname>Musgrave</surname><given-names>SD</given-names></name><name><surname>Malhotra</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>AJ</given-names></name><name><surname>Ayansina</surname><given-names>D</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name><name><surname>Tarassenko</surname><given-names>L</given-names></name><name><surname>Pagliari</surname><given-names>C</given-names></name><name><surname>Pinnock</surname><given-names>H</given-names></name></person-group><article-title>Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial</article-title><source>BMJ</source><year>2012</year><volume>344</volume><fpage>e1756</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.bmj.com/cgi/pmidlookup?view=long&amp;pmid=22446569"></ext-link></comment><pub-id pub-id-type="medline">22446569</pub-id><pub-id pub-id-type="pmid">22446569</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huckvale</surname><given-names>K</given-names></name><name><surname>Car</surname><given-names>M</given-names></name><name><surname>Morrison</surname><given-names>C</given-names></name><name><surname>Car</surname><given-names>J</given-names></name></person-group><article-title>Apps for asthma self-management: a systematic assessment of content and tools</article-title><source>BMC Med</source><year>2012</year><volume>10</volume><fpage>144</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/10/144"></ext-link></comment><pub-id pub-id-type="doi">10.1186/1741-7015-10-144</pub-id><pub-id pub-id-type="medline">23171675</pub-id><pub-id pub-id-type="pmid">23171675</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabana</surname><given-names>MD</given-names></name><name><surname>Rand</surname><given-names>CS</given-names></name><name><surname>Powe</surname><given-names>NR</given-names></name><name><surname>Wu</surname><given-names>AW</given-names></name><name><surname>Wilson</surname><given-names>MH</given-names></name><name><surname>Abboud</surname><given-names>PA</given-names></name><name><surname>Rubin</surname><given-names>HR</given-names></name></person-group><article-title>Why don't physicians follow clinical practice guidelines? A framework for improvement</article-title><source>JAMA</source><year>1999</year><month>10</month><day>20</day><volume>282</volume><issue>15</issue><fpage>1458</fpage><lpage>65</lpage><pub-id pub-id-type="medline">10535437</pub-id><pub-id pub-id-type="pmid">10535437</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grol</surname><given-names>R</given-names></name><name><surname>Wensing</surname><given-names>M</given-names></name></person-group><article-title>What drives change? Barriers to and incentives for achieving evidence-based practice</article-title><source>Med J Aust</source><year>2004</year><month>3</month><day>15</day><volume>180</volume><issue>6 Suppl</issue><fpage>S57</fpage><lpage>60</lpage><pub-id pub-id-type="medline">15012583</pub-id><pub-id pub-id-type="pmid">15012583</pub-id></element-citation></ref></ref-list></back></article>